Market Research Logo

Valeant Pharmaceuticals International Inc (VRX) - Product Pipeline Analysis, 2016 Update

Summary

Valeant Pharmaceuticals International Inc (Valeant) is a specialty pharmaceutical company. It carries out the development, manufacture and marketing of a wide range of specialty, over-the-counter (OTC) and generic drugs. The company also offers medical contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices. Valeant offers products in the areas of dermatology, neurology, eye health and branded generics. It offers a diverse mix of products in various regions across the world including the US, Canada, Australasia, Latin America, and Central and Eastern Europe. The company has manufacturing facilities in Canada and the US. Valeant is headquartered in Laval, Quebec, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Valeant Pharmaceuticals International Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Valeant Pharmaceuticals International Inc Company Overview
Valeant Pharmaceuticals International Inc Company Snapshot
Valeant Pharmaceuticals International Inc Pipeline Products and Clinical Trials Overview
Valeant Pharmaceuticals International Inc – Pipeline Analysis Overview
Business Description
Key Facts
Valeant Pharmaceuticals International Inc - Major Products and Services
Valeant Pharmaceuticals International Inc Pipeline Products by Development Stage
Valeant Pharmaceuticals International Inc Pipeline Products Overview
BLC - 001: SVS
BLC - 001: SVS Product Overview
BLC - 002: SVS
BLC - 002: SVS Product Overview
BLC - 003: SVS/MF/fA
BLC - 003: SVS/MF/fA Product Overview
BLC - 004: Toric
BLC - 004: Toric Product Overview
BLC - 005: SVS/MF
BLC - 005: SVS/MF Product Overview
BLC - 006: SVS
BLC - 006: SVS Product Overview
BLC - 007: MF
BLC - 007: MF Product Overview
BLC - 008: Astigmatism
BLC - 008: Astigmatism Product Overview
BLC - 009: Astigmatism
BLC - 009: Astigmatism Product Overview
BLS - 001: Cataract
BLS - 001: Cataract Product Overview
BLS - 002: Cataract
BLS - 002: Cataract Product Overview
BLS - 003: Cataract
BLS - 003: Cataract Product Overview
BLS - 004: Cataract
BLS - 004: Cataract Product Overview
BLS - 005: Retina
BLS - 005: Retina Product Overview
BLS - 006: Cataract
BLS - 006: Cataract Product Overview
BLS - 007: Cataract
BLS - 007: Cataract Product Overview
BLS - 008: Cataract
BLS - 008: Cataract Product Overview
BLS - 009: Retina
BLS - 009: Retina Product Overview
BLS - 010: Cataract
BLS - 010: Cataract Product Overview
BLS - 011: Cataract
BLS - 011: Cataract Product Overview
BLS - 012: Retina
BLS - 012: Retina Product Overview
BLS - 013: Retina
BLS - 013: Retina Product Overview
BLS - 014: Refractive
BLS - 014: Refractive Product Overview
BLS - 015: Cataract
BLS - 015: Cataract Product Overview
BLS - 016: Cataract
BLS - 016: Cataract Product Overview
BLS - 018: Retina
BLS - 018: Retina Product Overview
BLS - 019: Retina
BLS - 019: Retina Product Overview
BLS - 020: Retina
BLS - 020: Retina Product Overview
BLS - 021: Retina
BLS - 021: Retina Product Overview
BLS - 022: Retina
BLS - 022: Retina Product Overview
BLS - 023: Retina
BLS - 023: Retina Product Overview
BLS - 024: Retina
BLS - 024: Retina Product Overview
BLS - 025: Retina
BLS - 025: Retina Product Overview
BLS - 026: Retina
BLS - 026: Retina Product Overview
BLS - 027: Retina
BLS - 027: Retina Product Overview
BLS - 028: Retina
BLS - 028: Retina Product Overview
BLS - 029: Retina
BLS - 029: Retina Product Overview
BLS - 030: Retina
BLS - 030: Retina Product Overview
BLS - 031: Retina
BLS - 031: Retina Product Overview
Cirle 3-D Surgical Navigation System
Cirle 3-D Surgical Navigation System Product Overview
Customlens
Customlens Product Overview
Customshape
Customshape Product Overview
Intraoperative Device
Intraoperative Device Product Overview
LAV - 001: Aphakia
LAV - 001: Aphakia Product Overview
New Cooling System
New Cooling System Product Overview
Sarfarazi Elliptical Accommodating IOL
Sarfarazi Elliptical Accommodating IOL Product Overview
SOF - 010: Skin Resurfacing
SOF - 010: Skin Resurfacing Product Overview
SOM - 010: Vascular Lesions
SOM - 010: Vascular Lesions Product Overview
SonicEye Ultrasound Probe Vaser
SonicEye Ultrasound Probe Vaser Product Overview
SOT - 010: Fine Lines & wrinkles
SOT - 010: Fine Lines & wrinkles Product Overview
SOT - 011: Fine Lines & Wrinkles
SOT - 011: Fine Lines & Wrinkles Product Overview
Ultra Plus Powers Lens
Ultra Plus Powers Lens Product Overview
Ultra Toric Lens
Ultra Toric Lens Product Overview
Uriprene Stent
Uriprene Stent Product Overview
XUA - 001: Hair Removal
XUA - 001: Hair Removal Product Overview
XUV - 003: Aphakia
XUV - 003: Aphakia Product Overview
XUV - 004: SVS
XUV - 004: SVS Product Overview
XUV - 007: MF
XUV - 007: MF Product Overview
XUV - 009: SVS
XUV - 009: SVS Product Overview
XUV - 010: Astigmatism
XUV - 010: Astigmatism Product Overview
XUV - 011: MF
XUV - 011: MF Product Overview
XUV - 012: SVS
XUV - 012: SVS Product Overview
XUV - 013: Astigmatism
XUV - 013: Astigmatism Product Overview
XUV - 014: Presbyopia
XUV - 014: Presbyopia Product Overview
XUV - 015: MF
XUV - 015: MF Product Overview
Valeant Pharmaceuticals International Inc - Key Competitors
Valeant Pharmaceuticals International Inc - Key Employees
Valeant Pharmaceuticals International Inc - Key Employee Biographies
Valeant Pharmaceuticals International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Valeant Pharmaceuticals International Inc, Recent Developments
Dec 12, 2016: Valeant Appoints William D. Humphries As EVP, Dermatology
Nov 08, 2016: Valeant Reports Third Quarter 2016 Financial Results
Oct 06, 2016: Valeant Appoints Louis W. Yu, Ph.D. As Chief Quality Officer
Aug 22, 2016: Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief Financial Officer
Aug 10, 2016: Valeant Pharmaceuticals Comments On SDNY Investigation
Aug 09, 2016: Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results
Aug 08, 2016: Valeant Pharmaceuticals Announces Changes To Executive Management Team
Jul 28, 2016: Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors
Jul 13, 2016: Bausch + Lomb Announces Launch of EZ-24 Easy-Load Lens Delivery System for SofPort Advanced Optics Intraocular Lenses
Jun 30, 2016: New Bausch + Lomb Data Shows Outstanding Results For Presbyopic Patients In The Real World
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Valeant Pharmaceuticals International Inc Pipeline Products and Clinical Trials Overview
Valeant Pharmaceuticals International Inc Pipeline Products by Equipment Type
Valeant Pharmaceuticals International Inc Pipeline Products by Indication
Valeant Pharmaceuticals International Inc, Key Facts
Valeant Pharmaceuticals International Inc, Major Products and Services
Valeant Pharmaceuticals International Inc Number of Pipeline Products by Development Stage
Valeant Pharmaceuticals International Inc Pipeline Products Summary by Development Stage
BLC - 001: SVS - Product Status
BLC - 001: SVS - Product Description
BLC - 002: SVS - Product Status
BLC - 002: SVS - Product Description
BLC - 003: SVS/MF/fA - Product Status
BLC - 003: SVS/MF/fA - Product Description
BLC - 004: Toric - Product Status
BLC - 004: Toric - Product Description
BLC - 005: SVS/MF - Product Status
BLC - 005: SVS/MF - Product Description
BLC - 006: SVS - Product Status
BLC - 006: SVS - Product Description
BLC - 007: MF - Product Status
BLC - 007: MF - Product Description
BLC - 008: Astigmatism - Product Status
BLC - 008: Astigmatism - Product Description
BLC - 009: Astigmatism - Product Status
BLC - 009: Astigmatism - Product Description
BLS - 001: Cataract - Product Status
BLS - 001: Cataract - Product Description
BLS - 002: Cataract - Product Status
BLS - 002: Cataract - Product Description
BLS - 003: Cataract - Product Status
BLS - 003: Cataract - Product Description
BLS - 004: Cataract - Product Status
BLS - 004: Cataract - Product Description
BLS - 005: Retina - Product Status
BLS - 005: Retina - Product Description
BLS - 006: Cataract - Product Status
BLS - 006: Cataract - Product Description
BLS - 007: Cataract - Product Status
BLS - 007: Cataract - Product Description
BLS - 008: Cataract - Product Status
BLS - 008: Cataract - Product Description
BLS - 009: Retina - Product Status
BLS - 009: Retina - Product Description
BLS - 010: Cataract - Product Status
BLS - 010: Cataract - Product Description
BLS - 011: Cataract - Product Status
BLS - 011: Cataract - Product Description
BLS - 012: Retina - Product Status
BLS - 012: Retina - Product Description
BLS - 013: Retina - Product Status
BLS - 013: Retina - Product Description
BLS - 014: Refractive - Product Status
BLS - 014: Refractive - Product Description
BLS - 015: Cataract - Product Status
BLS - 015: Cataract - Product Description
BLS - 016: Cataract - Product Status
BLS - 016: Cataract - Product Description
BLS - 018: Retina - Product Status
BLS - 018: Retina - Product Description
BLS - 019: Retina - Product Status
BLS - 019: Retina - Product Description
BLS - 020: Retina - Product Status
BLS - 020: Retina - Product Description
BLS - 021: Retina - Product Status
BLS - 021: Retina - Product Description
BLS - 022: Retina - Product Status
BLS - 022: Retina - Product Description
BLS - 023: Retina - Product Status
BLS - 023: Retina - Product Description
BLS - 024: Retina - Product Status
BLS - 024: Retina - Product Description
BLS - 025: Retina - Product Status
BLS - 025: Retina - Product Description
BLS - 026: Retina - Product Status
BLS - 026: Retina - Product Description
BLS - 027: Retina - Product Status
BLS - 027: Retina - Product Description
BLS - 028: Retina - Product Status
BLS - 028: Retina - Product Description
BLS - 029: Retina - Product Status
BLS - 029: Retina - Product Description
BLS - 030: Retina - Product Status
BLS - 030: Retina - Product Description
BLS - 031: Retina - Product Status
BLS - 031: Retina - Product Description
Cirle 3-D Surgical Navigation System - Product Status
Cirle 3-D Surgical Navigation System - Product Description
Customlens - Product Status
Customlens - Product Description
Customshape - Product Status
Customshape - Product Description
Intraoperative Device - Product Status
Intraoperative Device - Product Description
LAV - 001: Aphakia - Product Status
LAV - 001: Aphakia - Product Description
New Cooling System - Product Status
New Cooling System - Product Description
Sarfarazi Elliptical Accommodating IOL - Product Status
Sarfarazi Elliptical Accommodating IOL - Product Description
SOF - 010: Skin Resurfacing - Product Status
SOF - 010: Skin Resurfacing - Product Description
SOM - 010: Vascular Lesions - Product Status
SOM - 010: Vascular Lesions - Product Description
SonicEye Ultrasound Probe Vaser - Product Status
SonicEye Ultrasound Probe Vaser - Product Description
SOT - 010: Fine Lines & wrinkles - Product Status
SOT - 010: Fine Lines & wrinkles - Product Description
SOT - 011: Fine Lines & Wrinkles - Product Status
SOT - 011: Fine Lines & Wrinkles - Product Description
Ultra Plus Powers Lens - Product Status
Ultra Plus Powers Lens - Product Description
Ultra Toric Lens - Product Status
Ultra Toric Lens - Product Description
Uriprene Stent - Product Status
Uriprene Stent - Product Description
XUA - 001: Hair Removal - Product Status
XUA - 001: Hair Removal - Product Description
XUV - 003: Aphakia - Product Status
XUV - 003: Aphakia - Product Description
XUV - 004: SVS - Product Status
XUV - 004: SVS - Product Description
XUV - 007: MF - Product Status
XUV - 007: MF - Product Description
XUV - 009: SVS - Product Status
XUV - 009: SVS - Product Description
XUV - 010: Astigmatism - Product Status
XUV - 010: Astigmatism - Product Description
XUV - 011: MF - Product Status
XUV - 011: MF - Product Description
XUV - 012: SVS - Product Status
XUV - 012: SVS - Product Description
XUV - 013: Astigmatism - Product Status
XUV - 013: Astigmatism - Product Description
XUV - 014: Presbyopia - Product Status
XUV - 014: Presbyopia - Product Description
XUV - 015: MF - Product Status
XUV - 015: MF - Product Description
Valeant Pharmaceuticals International Inc, Key Employees
Valeant Pharmaceuticals International Inc, Key Employee Biographies
Table 2: Valeant Pharmaceuticals International Inc, Other Locations
Valeant Pharmaceuticals International Inc, Subsidiaries
List of Figures
Valeant Pharmaceuticals International Inc Pipeline Products by Equipment Type
Valeant Pharmaceuticals International Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report